The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 2233–2256 of 3,535
Paragonix Technologies has unveiled **TempLock™**, a groundbreaking temperature stabilization technology integrated into its SherpaPak® Cardiac Transport System...
Royal Philips has secured **510(k) clearance** from the FDA for its Rembra platform, which includes Rembra CT, Rembra RT, and Areta RT systems. These advanced i...
A recent study from NYU Langone Health has identified a **routine blood marker**, specifically the **neutrophil to lymphocyte ratio (NLR)**, as a potential earl...
CytoDyn Inc. has presented promising early results from its ongoing Phase 2 study of **leronlimab**, a monoclonal antibody targeting the **CCR5 receptor**, in c...
Microbot Medical Inc. has garnered significant attention with its **LIBERTY® Endovascular Robotic System**, which aligns with the updated joint guidelines relea...
Cloudbreak Pharma Inc. is advancing its Multi Kinase Inhibitor (MKI) platform with promising candidates CBT-001 and CBT-004, targeting pterygium and pinguecula,...
Corbus Pharmaceuticals has announced updated clinical data from its Phase 1/2 study of **CRB-701**, a next-generation **Nectin-4 antibody-drug conjugate (ADC)**...
Neurona Therapeutics has reported promising results from its ongoing Phase 1/2 trials evaluating **rezanecel (NRTX-1001)**, an allogeneic interneuron cell thera...
CervoMed Inc. presented groundbreaking findings at the 2026 AAN Annual Meeting, demonstrating that **neflamapimod** may reverse atrophy in the **basal forebrain...
Alterity Therapeutics has presented promising data from its Phase 2 trial of **ATH434**, a novel treatment for **Multiple System Atrophy (MSA)**, demonstrating...
Luminoah has received FDA clearance for **Luminoah Flow™**, an innovative enteral feeding system aimed at enhancing the experience of patients reliant on tube f...
New preclinical findings presented by BeyondSpring Inc. at the AACR 2026 conference reveal that **Plinabulin** significantly enhances the efficacy of antibody-d...
Recent research has elucidated the **age-related degeneration of the pineal gland (PG)**, focusing on its structural disruptions and the role of astrocytes. The...
Researchers have re-evaluated the **Gompertz law** parameters α and β, traditionally used to describe mortality rates in aging populations, through the lens of...
AtaiBeckley Inc. has reported promising results from its Phase 2a trial of **EMP-01** (oral R-MDMA) in adults with **Social Anxiety Disorder (SAD)**. The study,...
Blue Mountain, a leader in Enterprise Asset Management (EAM) software for life sciences, has announced the acquisition of CompuCal Calibration Solutions, a reco...
**Blue Mountain has announced the acquisition of CompuCal Calibration Solutions, enhancing its position in the European life sciences sector. This strategic mov...
Blue Mountain, a leader in GMP-compliant Enterprise Asset Management (EAM) software for the life sciences sector, has announced its acquisition of CompuCal Cali...
AstraZeneca has announced promising results from the Phase III MIRANDA trial, demonstrating that **tozorakimab 300 mg**, administered biweekly alongside standar...
Insilico Medicine has established the **first Longevity Board** in the biotechnology sector, aimed at providing scientific oversight and strategic guidance for...
Inbrain Neuroelectronics has successfully completed patient recruitment for its first-in-human study of a **graphene cortical interface** (NCT06368310), involvi...
**Medicines360 and Pharma Dynamics have launched AVIBELA**, South Africa's first generic levonorgestrel 52 mg intrauterine device (IUD), significantly enhancing...
Rakovina Therapeutics Inc. has unveiled promising preclinical data from two lead programs at the 2026 AACR Annual Meeting, showcasing advancements in AI-driven...
Elkedonia has appointed **Pierre d'Epenoux** as the independent Chairman of its Strategic Committee, enhancing its governance as the company advances its innova...
